Neoplasia/BPH

	Toxicity of rectal preparation strategies in ultra-hypofractionated SBRT for prostate cancer. Tech Innov Patient Support Radiat Oncol van der Walle R, Staal FHE, Janssen J, Langendijk JA, Brouwer CL, Aluwini S. PMID: 42064969 [PubMed]
	Do AI-based contouring algorithms influence physicians in the online adaptive radiotherapy of patients with bladder cancer? Tech Innov Patient Support Radiat Oncol Guberina N, Khouya A, Hoffmann C, Fischedick G, Alberti Y, Hlouschek J, Freisleben F, Herz A, Ton MTT, Kiwitt LO, Sahin EC, Santiago Garcia A, Gauler T, Pöttgen C, Guberina M, Stuschke M. PMID: 42064968 [PubMed]
	Real-world costs per life-year of targeted therapy, incidence, lifetime health impact, and medical costs of renal cell carcinoma in Taiwan. Front Public Health Lu CH, Tung MC, Ou YC, Chiu YM, Tse SS, Chang CC. PMID: 42064902 [PubMed - indexed for MEDLINE]
	From incidentaloma to actionable insight: a clinical-molecular-imaging framework for risk-stratified management of testicular microlithiasis. Front Endocrinol (Lausanne) Zhou J, Ouyang Y, Hu S, Xiong Y, Liu M. PMID: 42064772 [PubMed - indexed for MEDLINE]
	TFE3-rearranged renal cell carcinoma - Morphology and differential diagnosis. Urol Case Rep Murugesan I, Yadav M, Kumar U, Agarwal P, Data S. PMID: 42064255 [PubMed]
	PSMA-directed CAR-T cell therapy for metastatic castration-resistant prostate cancer: a next-generation engineering perspective on stem cell-derived immune effectors. Front Immunol Zhang M, Li H, Liao K. PMID: 42064077 [PubMed - indexed for MEDLINE]
	Construction and validation of a multimodal MRI-based deep learning model for early differential diagnosis of prostate cancer in the PSA gray zone: a retrospective cohort study. Front Oncol Xu Z, Ren D, Wang G, Liu H, Zhou Y, Zhu X. PMID: 42063732 [PubMed]
	Association between CYP1A1 gene polymorphisms at rs4646903 and rs1048943 loci and susceptibility to prostate cancer: meta-analysis. Front Oncol Teng R, Yu P, Teng Z, Feng Y. PMID: 42063720 [PubMed]
	Lymph node dissection during cystectomy for non-muscle-invasive bladder cancer: A systematic review. BJUI Compass Lim S, Standish L, Liu H, Paul E, Ranasinghe W. PMID: 42063588 [PubMed]
	Diet in Prostate Cancer: Promising Side Dish or Main Course? Cancer Epidemiol Biomarkers Prev Galván GC, Hernandez-Tirado A, Friedrich NA, Freedland SJ. PMID: 42063321 [PubMed - indexed for MEDLINE]
	Diagnostic and prognostic utility of PSMA-PET/CT in node-metastatic prostate cancer. BJU Int Pickersgill NA, Yu R, Vertosick EA, Fletcher SA, Liso N, Kluckert J, Akin O, Ehdaie B, Laudone VP, Eastham JA, Vickers AJ, Touijer KA, Gaffney CD. PMID: 42063278 [PubMed - as supplied by publisher]
	A meta-analysis of dizziness as an adverse reaction in novel endocrine therapy for advanced prostate cancer. BMC Cancer Xue W, Zhang P, Quan J. PMID: 42062949 [PubMed - as supplied by publisher]
	Genetic characteristics and targeted treatments of primary bladder and urachal adenocarcinomas: a systematic review with pooled descriptive genomic analyses. Cancer Metastasis Rev Dér B, Váradi M, Nagy N, Kubik A, Paner GP, Iyer G, Gaisa NT, Wobker SE, Bambury R, van Rhijn BWG, Al-Ahmadie H, Nyirády P, Reis H, Szarvas T. PMID: 42062619 [PubMed - indexed for MEDLINE]
	Time to rethink routine histopathology after adult circumcision? Long-term oncological outcomes from an 11-year cohort. World J Urol Nandwani GM, Hassan M, Lohana D, Bollina P. PMID: 42062611 [PubMed - indexed for MEDLINE]
	CLO26-075: Are PARP Inhibitors Effective Beyond Homologous Recombination Repair-Deficiency in Castration-Resistant Prostate Cancer? A Meta-Analysis. J Natl Compr Canc Netw Zhou S, Desai D, Benjamin S, Tsao CK. PMID: 42061439 [PubMed - in process]
	On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trials. Lancet Oncol Kayani M, Murphy L, Dutey-Magni P, Howlett S, Sachdeva A, Padden-Modi M, Abdel-Aty H, Brown LC, Amos CL, Chan K, Gilbert DC, Langley RE, Brown M, Sydes MR, Parker CC, STAMPEDE Collaborators, Cross W, Malik Z, Varughese M, Turco F, Millman R, Matheson D, Gillessen S, Clarke NW, Parmar MKB, James ND, Attard G. PMID: 42061373 [PubMed - indexed for MEDLINE]
	PRECISE Version 2: Essential Tips for Prostate Cancer Monitoring Using MRI. Radiographics Ogata A, Brembilla G, Dias AB, Barrett T, Canedo IB, Girometti R, Gouvea GL, Lima TA, Moore CM, Nicola R, Panebianco V, Renard-Penna R, Westphalen AC, Muglia VF, Giganti F. PMID: 42060486 [PubMed - indexed for MEDLINE]
	Local Salvage Therapy Alone for Local Recurrence of Prostate Cancer After Radiotherapy: A Systematic Review and Meta-Analysis. JAMA Oncol Miszczyk M, Mastroleo F, Kujawska A, Gurwin A, Marvaso G, Kói T, Calleris G, Rasing M, Chin J, Fuller D, Nathan A, Peters M, van der Voort van Zyp J, Jenjitranant P, Hruby G, Soeterik TFW, Francolini G, Exterkate L, Overduin CG, Marra G, Gontero P, Alfarhan AR, Rajwa P, Kishan AU, Jereczek-Fossa BA, Shariat SF, DEFER-PC Collaborators. PMID: 42060279 [PubMed - as supplied by publisher]
	Management of lower urinary tract symptoms before prostate cancer radiotherapy: a call for innovative strategies. World J Urol Le Guevelou J, Anract J, Dariane C, Scheltema M, Bernardino R, Bianchi L, Kasivisvanathan V, Sibona M, Mari A, Sapoval M, Miszczyk M, Rajwa P, Boeken T, Marra G, YAU Prostate Group. PMID: 42059970 [PubMed - indexed for MEDLINE]
	PSMA PET: the answer to MRI-occult prostate cancerâ€¦ or another mirage? Eur Radiol Wagner T, Emberton M, Caglic I, Priftakis D, Giganti F, Kasivisvanathan V, Punwani S. PMID: 42059962 [PubMed - as supplied by publisher]

Articles 1 - 20 / 187478

Page 1 of 9374



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy